FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37143511000001102: Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jun 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
233261000001115 Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
233271000001113 Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Is a Fingolimod 250microgram capsules 28 capsule true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Has AMP Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Has specific active ingredient Fingolimod hydrochloride true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Fingolimod true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd) 28 capsule 2 x 14 capsules Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start